Teva survey finds COVID has 'widened the chasm' on health disparities

By now, it’s no surprise that the global pandemic has worsened long-standing health inequities—and pharma has stepped up with a flood of initiatives to try to tackle the problem.

But a new Harris Poll commissioned by Israel-based generics giant Teva Pharmaceuticals and the Morehouse School of Medicine in Atlanta shows just how much work the industry and others have left to do.